A
83/100
Intellia Therapeutics Claimed Company
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. read more
HR or Marketing? Claim Your Free Employer Account
Intellia Therapeutics Outlook Employee Reviews
All
Positive
Constructive
What makes you most happy at work?
How much emphasis there is on learning
What's going wrong and how can it be improved?
There aren't any Outlook reviews of Intellia Therapeutics yet.
Be the first to contribute a review.
What do you like best about your company?
There aren't any Outlook reviews of Intellia Therapeutics yet.
Be the first to contribute a review.
What would you most like to see improved at your company?
There aren't any Outlook reviews of Intellia Therapeutics yet.
Be the first to contribute a review.
×